COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1866.3 | 6 | 0023-0104 | 359.67 | 103.66 | 639 | 92.91 | 0.930 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 235.9 | 6 | 0024-0101 | 917.18 | 101.30 | 370 | 71.01 | 0.922 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 246.6 | 6 | 0025-0102 | 147.44 | 102.15 | 426 | 79.01 | 0.857 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 268.6 | 6 | 0026-0104 | 203.96 | 103.60 | 391 | 73.84 | 0.901 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 302.9 | 6 | 0027-0111 | 687.18 | 111.25 | 425 | 77.26 | 0.895 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 254.1 | 6 | 0028-0114 | 311.62 | 114.67 | 409 | 76.67 | 0.874 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 496.6 | 6 | 0029-0126 | 567.48 | 126.76 | 529 | 119.88 | 0.463 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 322.1 | 6 | 0030-0124 | 514.48 | 124.06 | 399 | 73.60 | 0.926 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 253.1 | 6 | 0031-0134 | 874.24 | 134.51 | 416 | 75.26 | 0.923 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 311.7 | 6 | 0032-0136 | 443.35 | 136.30 | 428 | 77.26 | 0.901 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 257.9 | 6 | 0033-0137 | 221.07 | 136.76 | 398 | 74.43 | 0.903 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 296.0 | 6 | 0034-0138 | 802.41 | 138.59 | 416 | 75.01 | 0.929 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 212.8 | 6 | 0035-0141 | 845.01 | 141.60 | 424 | 79.50 | 0.843 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 401.7 | 6 | 0036-0145 | 932.34 | 145.11 | 411 | 78.77 | 0.832 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 286.9 | 6 | 0037-0156 | 316.95 | 156.18 | 405 | 75.26 | 0.899 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 670.4 | 6 | 0038-0173 | 180.35 | 172.98 | 600 | 120.37 | 0.520 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 289.9 | 6 | 0039-0171 | 928.07 | 170.09 | 399 | 76.53 | 0.856 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 231.0 | 6 | 0040-0176 | 889.94 | 176.64 | 383 | 76.67 | 0.819 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 282.5 | 6 | 0041-0180 | 641.53 | 180.47 | 408 | 74.43 | 0.926 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 261.8 | 6 | 0042-0181 | 254.12 | 181.22 | 431 | 79.84 | 0.850 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 322.5 | 6 | 0043-0180 | 575.01 | 180.53 | 356 | 69.01 | 0.939 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 247.3 | 6 | 0044-0185 | 769.00 | 185.35 | 487 | 85.84 | 0.831 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 313.7 | 6 | 0045-0201 | 840.71 | 200.64 | 409 | 78.91 | 0.825 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 306.2 | 6 | 0046-0201 | 402.79 | 201.96 | 404 | 75.84 | 0.883 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 298.5 | 6 | 0047-0217 | 557.64 | 217.97 | 437 | 78.18 | 0.898 |